LicianPro

FENNEC PHARMACEUTICALS INC. ·

FENC 8-K 2026-09-17

FENNEC PHARMACEUTICALS INC. (FENC) 8-K dated 2026-09-17 — accession 0001104659-26-108565.

FENNEC PHARMACEUTICALS INC. (FENC) is a biotechnology company listed on US.

FENNEC PHARMACEUTICALS INC. filed a 8-K on 2026-09-17. Accession 0001104659-26-108565.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported FENC revenue for 2025-12-31 was $44.6M. Net income was -$9.7M. Revenue was down 6.1% from 2024-12-31 to 2025-12-31. FENC currently screens at market cap $302.2M.

Not investment advice. The FENC SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr